Le Lézard
Classified in: Health, Business

RegeneRx Releases Annual Letter to Shareholders



ROCKVILLE, Md., Dec. 7, 2017 /PRNewswire/ --RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that its year end letter to shareholders. The letter is focused on updating shareholders on the Company's product development and commercial partnerships, clinical trials, fund-raising, and other operational plans over the next twelve months. To view the letter, please go to www.regenerx.com.

Forward Looking Statements
Any statements in this shareholder letter that are not historical facts are forward-looking statements made under the provisions of the Private Securities Litigation Reform Act of 1995. Any forward-looking statements involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Forward-looking statements in this shareholder letter include, but are not limited to, statements regarding our strategic and research partnerships, future royalty and milestone payments, regulatory applications and approvals, the development of our drug candidates, the use of our drug candidates to treat various conditions, our growth strategy, and our financial needs. The proposed clinical trials and costs and resources to support such trials, as well as the other forward-looking statements, are expectations and estimates based upon information obtained and calculated by the Company at this time and are subject to change. Moreover, there is no guarantee any of these trials will be successful or confirm previous clinical results. Please view these and other risks described in the Company's filings with the Securities and Exchange Commission ("SEC"), including those identified in the "Risk Factors" section of the annual report on Form 10-K for the year ended December 31, 2016, and subsequent quarterly reports filed on Form 10-Q, as well as other filings it makes with the SEC. Any forward-looking statements in this shareholder letter represent the Company's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. The Company specifically disclaims any obligation to update this information, as a result of future events or otherwise, except as required by applicable law.

SOURCE RegeneRx Biopharmaceuticals, Inc.


These press releases may also interest you

at 08:00
BIRMINGHAM, Ala., Nov. 17, 2018 /PRNewswire-PRWeb/ -- There's little doubt when the time comes when a family needs a door wreath, ceremony flowers, or related items, they don't want to cut back on quality or dependable delivery. The good news is that...

at 08:00
Carinsuranceplan.org has released a new blog post that explains how to change the current car insurance provider in 6 easy-to-follow steps. There are times in life when a change is needed. That moment may come when analyzing the insurance costs and...

at 08:00
SEOUL, South Korea, Nov. 17, 2018 /PRNewswire-PRWeb/ -- The social TV platform provider Salin (http://www.salin.co.kr) has partnered with local companies specializing in content production to create a new market for VR content. The company is known...

at 06:11
Bitstraq exchange has notified the Maltese Regulator, the MFSA (Malta Financial Services Authority) that it intends to avail itself of the 12-month transitory period to apply for a Virtual Financial Assets (VFA) License as a Class 4 VFA Service...

at 06:00
The Honourable Mélanie Joly, Minister of Tourism, Official Languages and La Francophonie, will participate in roundtable discussions with local tourism and travel industry experts. These will help identify opportunities to maximize Canada's tourism...

at 03:00
ASHEVILLE, N.C., Nov. 17, 2018 /PRNewswire-PRWeb/ -- RMD's might not sound too important to the average investor, but as they relate to anyone with a Self-Directed IRA, they can be a vital part of planning for retirement. RMDs stand for Required...




News published on 7 december 2017 at 14:33 and distributed by: